Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$379M |
| 2 |
Starbucks
SBUX
|
+$371M |
| 3 |
APC
Anadarko Petroleum
APC
|
+$287M |
| 4 |
Bristol-Myers Squibb
BMY
|
+$263M |
| 5 |
Tesla
TSLA
|
+$253M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Fortive
FTV
|
+$1.27B |
| 2 |
ANDV
Andeavor
ANDV
|
+$1.11B |
| 3 |
AET
Aetna Inc
AET
|
+$535M |
| 4 |
Microsoft
MSFT
|
+$350M |
| 5 |
Amazon
AMZN
|
+$290M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 13.69% |
| 2 | Technology | 13.64% |
| 3 | Financials | 12.49% |
| 4 | Consumer Discretionary | 10.83% |
| 5 | Industrials | 9.5% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
AKS
1176
DELISTED
AK Steel Holding Corp
AKS
| $9.17M | 0.01% |
4,075,819
+2,125,128
| +109% | +$7.68M |
|
1177
Transocean
RIG
$6.42B
| $9.17M | 0.01% |
1,321,192
-787,954
| -37% | -$8.03M |
|
|
CLGX
1178
DELISTED
Corelogic, Inc.
CLGX
| $9.16M | 0.01% |
274,183
+23,889
| +10% | +$969K |
|
1179
Principal Financial Group
PFG
$23.9B
| $9.16M | 0.01% |
+207,306
| New | +$10.2M |
|
|
CBAY
1180
DELISTED
Cymabay Therapeutics
CBAY
| $9.15M | 0.01% |
1,163,152
+253,377
| +28% | +$2.41M |
|
1181
Darling Ingredients
DAR
$9.88B
| $9.14M | 0.01% |
475,220
-177,579
| -27% | -$3.6M |
|
|
ATVI
1182
DELISTED
Activision Blizzard
ATVI
| $9.14M | 0.01% |
196,242
-1,258,372
| -87% | -$75.3M |
|
1183
Federal Signal
FSS
$7.36B
| $9.13M | 0.01% |
458,558
+9,883
| +2% | +$225K |
|
1184
FS KKR Capital
FSK
$3.33B
| $9.12M | 0.01% |
440,275
+382,875
| +667% | +$9.53M |
|
1185
Children's Place
PLCE
$59.8M
| $9.12M | 0.01% |
101,239
+96,999
| +2,288% | +$12.1M |
|
1186
Vodafone
VOD
$37.3B
| $9.11M | 0.01% |
472,603
-1,112,292
| -70% | -$22.2M |
|
1187
Kilroy Realty
KRC
$4.33B
| $9.08M | 0.01% |
+144,337
| New | +$9.88M |
|
|
DPLO
1188
DELISTED
DIPLOMAT PHARMACY, INC.
DPLO
| $9.07M | 0.01% |
673,940
+44,896
| +7% | +$757K |
|
1189
BioMarin Pharmaceuticals
BMRN
$12.8B
| $9.05M | 0.01% |
106,292
-228,550
| -68% | -$21.7M |
|
1190
Shutterstock
SSTK
$205M
| $9.05M | 0.01% |
251,260
+69,840
| +38% | +$2.85M |
|
|
CCI.PRA
1191
DELISTED
Crown Castle International Corp. 6.875% Mandatory Convertible Preferred Stock, Series A
CCI.PRA
| $9.02M | 0.01% |
+8,574
| New | +$9.03M |
|
1192
Compañía de Cervecerías Unidas
CCU
$2.32B
| $9.01M | 0.01% |
358,418
-100,012
| -22% | -$2.59M |
|
1193
H&R Block
HRB
$6.56B
| $8.98M | 0.01% |
354,169
-649,138
| -65% | -$17.3M |
|
1194
Kennametal
KMT
$2.23B
| $8.98M | 0.01% |
269,935
-194,501
| -42% | -$7.38M |
|
1195
W&T Offshore
WTI
$543M
| $8.95M | 0.01% |
2,171,207
+833,861
| +62% | +$5.33M |
|
1196
Corcept Therapeutics
CORT
$13.4B
| $8.94M | 0.01% |
668,837
+612,518
| +1,088% | +$8.1M |
|
1197
Employers Holdings
EIG
$876M
| $8.9M | 0.01% |
212,071
+59,111
| +39% | +$2.59M |
|
1198
CoStar Group
CSGP
$13.3B
| $8.9M | 0.01% |
263,820
-327,560
| -55% | -$12M |
|
1199
Franklin Templeton
BEN
$17.8B
| $8.88M | 0.01% |
299,462
+275,303
| +1,140% | +$8.47M |
|
1200
Stratasys
SSYS
$693M
| $8.87M | 0.01% |
492,329
+410,983
| +505% | +$8.59M |
|
Similar funds
Israel Englander's Q4 2018 Portfolio in Review
As of Q4 2018, Israel Englander held 4,541 positions worth $64.1B, down 21% from $81.6B the previous quarter. Its ten largest holdings account for 6.7% of the portfolio.
Israel Englander withdrew a net $4.25B in Q4 2018, closing 844 positions and reducing 1,571 holdings. Its most notable exit was Andeavor, an estimated $1.11B position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 14% of assets, up from 12% a quarter earlier, followed by Technology and Financials.
Against the trend, Israel Englander opened a new position in Athenahealth, Inc. worth $135M.
- Israel Englander's largest Q4 2018 buy was Athenahealth, Inc.: 1,022,505 shares worth $135M.
- Israel Englander added most to Celgene Corp in Q4 2018, an estimated $379M increase.
- Israel Englander's biggest Q4 2018 reduction was Fortive, cutting an estimated $1.27B.
- Israel Englander fully exited Andeavor in Q4 2018, selling an estimated $1.11B.
- Israel Englander's ten largest holdings make up 6.7% of its $64.1B portfolio in Q4 2018.
- Israel Englander opened 702 new positions and closed 844 in Q4 2018.
- Israel Englander's portfolio value fell 21% quarter-over-quarter to $64.1B.
Based on Millennium Management's 13F filing for Q4 2018, filed 14 Feb 2019.